Hypersensitivity Pneumonitis Market - Top Companies and Manufacturers

In the News

• Pfizer Inc. received approval from the U.S. Food and Drug Administration (FDA) for metastatic non-small cell lung cancer which is the second most common type of cancer in the world.
• Sanofi S.A. an innovative global healthcare company announced that it has received approval from the U.S. Food and Drug Administration (FDA) for Dupixent (dupilumab) a monoclonal antibody used to treat allergic conditions such as, asthma. Further, is the first and only biologic drug authorized for the treatment of moderate-to-severe atopic dermatitis, and the children treated with Dupixent with topical corticosteroids (TCS) reported that they had cleaner skin and considerably less itching.